Cancer chemoprevention: progress and promise
- PMID: 10673988
- DOI: 10.1016/s0959-8049(99)00164-1
Cancer chemoprevention: progress and promise
Abstract
Cancer chemoprevention is the use of agents to inhibit, delay or reverse carcinogenesis. The focus of chemoprevention research in the next millennium will include defining the genotypic and phenotypic (functional and histological) changes during carcinogenesis, the cancer risk conferred by these changes, their modulation in preclinical experimentation and randomised clinical trials by chemopreventive drugs, dietary agents and regimens and treatments resulting from early detection. The key elements of this research effort will be basic and translational risk evaluation programmes; chemopreventive and dietary agent drug discovery and development; development of transgenic animal models; required safety and pharmacology studies; well-designed phase I, II and III chemoprevention studies; and much expanded early detection programmes. The large number of chemoprevention research programmes now ongoing ensures that the promise of chemoprevention will continue to be realised in the next decade.
Similar articles
-
Cancer chemoprevention: progress and promise.Eur J Cancer. 1999 Dec;35(14):2031-8. doi: 10.1016/s0959-8049(99)00299-3. Eur J Cancer. 1999. PMID: 10711244 Review.
-
The role of chemoprevention in cancer control.IARC Sci Publ. 1996;(139):13-22. IARC Sci Publ. 1996. PMID: 8923016 Review.
-
Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.J Cell Biochem Suppl. 1996;25:29-36. J Cell Biochem Suppl. 1996. PMID: 9027595 Review.
-
Cancer chemoprevention. A new way to treat cancer before it happens.Prim Care. 1998 Jun;25(2):361-79. doi: 10.1016/s0095-4543(05)70069-5. Prim Care. 1998. PMID: 9628956 Review.
-
Risk biomarkers and current strategies for cancer chemoprevention.J Cell Biochem Suppl. 1996;25:1-14. J Cell Biochem Suppl. 1996. PMID: 9027592 Review.
Cited by
-
Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.J Cell Mol Med. 2018 Sep;22(9):4423-4436. doi: 10.1111/jcmm.13742. Epub 2018 Jul 11. J Cell Mol Med. 2018. PMID: 29993186 Free PMC article.
-
Quinone reductase induction as a biomarker for cancer chemoprevention.J Nat Prod. 2006 Mar;69(3):460-3. doi: 10.1021/np050362q. J Nat Prod. 2006. PMID: 16562858 Free PMC article. Review.
-
Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function.Cancer Prev Res (Phila). 2014 Nov;7(11):1149-59. doi: 10.1158/1940-6207.CAPR-14-0091. Epub 2014 Sep 22. Cancer Prev Res (Phila). 2014. PMID: 25245764 Free PMC article.
-
Introduction: Cancer chemoprevention and its context.Semin Oncol. 2016 Feb;43(1):19-21. doi: 10.1053/j.seminoncol.2015.11.002. Epub 2015 Nov 10. Semin Oncol. 2016. PMID: 26970121 Free PMC article. No abstract available.
-
Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer.Carcinogenesis. 2012 Dec;33(12):2601-10. doi: 10.1093/carcin/bgs300. Epub 2012 Oct 1. Carcinogenesis. 2012. PMID: 23027624 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources